These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 39244972)

  • 1. FL118: A potential bladder cancer therapeutic compound targeting H2A.X identified through library screening.
    Fan G; Luo X; Shi Y; Wang Y; Ji L; Gong Y; Yang E; Chen C; Cui S; Ding H; Zhang Z; Wang J; Liu Y; Wang Z
    Bioorg Chem; 2024 Dec; 153():107802. PubMed ID: 39244972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enabling Systemic Identification and Functionality Profiling for Cdc42 Homeostatic Modulators.
    Malasala S; Azimian F; Chen YH; Twiss JL; Boykin C; Akhtar SN; Lu Q
    bioRxiv; 2024 Jan; ():. PubMed ID: 38260445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a novel toxicophore in anti-cancer chemotherapeutics that targets mitochondrial respiratory complex I.
    Stephenson ZA; Harvey RF; Pryde KR; Mistry S; Hardy RE; Serreli R; Chung I; Allen TE; Stoneley M; MacFarlane M; Fischer PM; Hirst J; Kellam B; Willis AE
    Elife; 2020 May; 9():. PubMed ID: 32432547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of anti-inflammatory and anti-cancer compounds targeting the NF-κB-NLRP3 inflammasome pathway from a phytochemical library of the Sideritis genus.
    Yücer R; Schröder A; Topçu G; Efferth T
    J Ethnopharmacol; 2025 Feb; 338(Pt 2):119074. PubMed ID: 39522840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model.
    Harnan S; Kearns B; Scope A; Schmitt L; Jankovic D; Hamilton J; Srivastava T; Hill H; Ku CC; Ren S; Rothery C; Bojke L; Sculpher M; Woods B
    Health Technol Assess; 2024 Oct; 28(73):1-230. PubMed ID: 39487661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cepharanthine sensitizes gastric cancer cells to chemotherapy by targeting TRIB3-FOXO3-FOXM1 axis to inhibit autophagy.
    Lu YY; Fang YY; Wang SS; Guo J; Song JL; Zhu L; Lin ZK; Wang R; Zhang SY; Qiu WS; Qi WW
    Phytomedicine; 2024 Dec; 135():156161. PubMed ID: 39454374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defining the optimum strategy for identifying adults and children with coeliac disease: systematic review and economic modelling.
    Elwenspoek MM; Thom H; Sheppard AL; Keeney E; O'Donnell R; Jackson J; Roadevin C; Dawson S; Lane D; Stubbs J; Everitt H; Watson JC; Hay AD; Gillett P; Robins G; Jones HE; Mallett S; Whiting PF
    Health Technol Assess; 2022 Oct; 26(44):1-310. PubMed ID: 36321689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EGCG targeting STAT3 transcriptionally represses PLXNC1 to inhibit M2 polarization mediated by gastric cancer cell-derived exosomal miR-92b-5p.
    Yi J; Ye Z; Xu H; Zhang H; Cao H; Li X; Wang T; Dong C; Du Y; Dong S; Zhou W
    Phytomedicine; 2024 Dec; 135():156137. PubMed ID: 39566403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quinazoline derivatives inhibit cell growth of prostate cancer as a WRN helicase dependent manner by regulating DNA damage repair and microsatellite instability.
    Yu J; Zhou Y; Liang G; Cheng S; Wei J; Li H; Liu X; You C; Mao M; Ahmad M; Yu G; Xu B; Luo H
    Bioorg Chem; 2024 Dec; 153():107963. PubMed ID: 39571305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rational fragment-based design of compounds targeting the PWWP domain of the HRP family.
    Vantieghem T; Aslam NA; Osipov EM; Akele M; Van Belle S; Beelen S; Drexler M; Paulovcakova T; Lux V; Fearon D; Douangamath A; von Delft F; Christ F; Veverka V; Verwilst P; Van Aerschot A; Debyser Z; Strelkov SV
    Eur J Med Chem; 2024 Dec; 280():116960. PubMed ID: 39461037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genedrive kit for detecting single nucleotide polymorphism m.1555A>G in neonates and their mothers: a systematic review and cost-effectiveness analysis.
    Shabaninejad H; Kenny RP; Robinson T; Stoniute A; O'Keefe H; Still M; Thornton C; Pearson F; Beyer F; Meader N
    Health Technol Assess; 2024 Oct; 28(75):1-75. PubMed ID: 39487741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Icariin promoted ferroptosis by activating mitochondrial dysfunction to inhibit colorectal cancer and synergistically enhanced the efficacy of PD-1 inhibitors.
    Haoyue W; Kexiang S; Shan TW; Jiamin G; Luyun Y; Junkai W; Wanli D
    Phytomedicine; 2024 Nov; 136():156224. PubMed ID: 39642461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abrocitinib, tralokinumab and upadacitinib for treating moderate-to-severe atopic dermatitis.
    Edwards SJ; Karner C; Jhita T; Barton S; Marceniuk G; Yiu ZZN; Wittmann M
    Health Technol Assess; 2024 Jan; 28(4):1-113. PubMed ID: 38343072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gambogic acid impairs the maintenance and therapeutic resistance of glioma stem cells by targeting B-cell-specific Moloney leukemia virus insert site 1.
    Sun T; Lin B; Sun Q; Zhang X; Wang T; Yang J; Liu X; Lu H; Lu N; Zhao K
    Phytomedicine; 2024 Dec; 135():156070. PubMed ID: 39326139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of interpersonal psychotherapy in comparison to other psychological and pharmacological interventions for reducing depressive symptoms in women diagnosed with postpartum depression in low- and middle-income countries: A systematic review.
    Kang HK; Bisht B; Kaur M; Alexis O; Worsley A; John D
    Campbell Syst Rev; 2024 Jun; 20(2):e1399. PubMed ID: 38645302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs.
    Marson AG; Burnside G; Appleton R; Smith D; Leach JP; Sills G; Tudur-Smith C; Plumpton CO; Hughes DA; Williamson PR; Baker G; Balabanova S; Taylor C; Brown R; Hindley D; Howell S; Maguire M; Mohanraj R; Smith PE
    Health Technol Assess; 2021 Dec; 25(75):1-134. PubMed ID: 34931602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unlocking data: Decision-maker perspectives on cross-sectoral data sharing and linkage as part of a whole-systems approach to public health policy and practice.
    Tweed E; Cimova K; Craig P; Allik M; Brown D; Campbell M; Henderson D; Mayor C; Meier P; Watson N
    Public Health Res (Southampt); 2024 Nov; ():1-30. PubMed ID: 39582242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of flavonoid-containing compound Lupalbigenin as anti-NSCLC cancer agents via suppression of EGFR and ERK1/2 pathway.
    Cuan X; Yang X; Wang J; Sheng J; Wang X; Huang Y
    Bioorg Chem; 2024 Dec; 153():107808. PubMed ID: 39288634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of a Novel and Potent Dual-Targeting Inhibitor of ATM and HDAC2 Through Structure-Based Virtual Screening for the Treatment of Testicular Cancer.
    Ruan Y; Guan L; Wang Y; Geng Y; Wang X; Niu MM; Yang L; Xu C; Xu Z
    Drug Des Devel Ther; 2024; 18():5283-5297. PubMed ID: 39583632
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.